NYSE · ECVTMaterialsChemicals

Ecovyst financials

$9.80−2.39%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
Revenue$723.5M$598.3M$584.8M$820.2M$611.2M
Gross profit$158.1M$163.4M$166.4M$224.6M$176.7M
Gross margin21.8%27.3%28.5%27.4%28.9%
Operating income$64.9M$85.1M$89.6M$104.4M$54.6M
Net income-$71.1M-$6.7M$71.2M$73.7M-$139.9M
Net margin−9.8%−1.1%12.2%9.0%−22.9%
Diluted EPS$-0.61$-0.06$0.60$0.55$-1.02
EBITDA$143.5M$155.7M$155.6M$183.5M$134.3M
Operating cash flow$140.3M$149.9M$137.6M$186.6M$129.9M
Free cash flow$69.9M$94.3M$78.6M$127.7M$69.9M
Diluted shares116.0M117.4M119.5M135.1M137.7M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$197.2M$131.4M$88.4M$110.9M$140.9M
Short-term investments$0.00$0.00$0.00$0.00—
Total debt$392.6M$860.8M$867.9M$874.9M$881.8M
Total assets$1.26B$1.80B$1.84B$1.88B$1.93B
Total liabilities$657.5M$1.10B$1.13B$1.18B$1.19B
Shareholders' equity$603.4M$700.5M$705.5M$707.2M$740.7M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology